AAAAAA

   
Results: 1-21 |
Results: 21
PICTURE OF THE MONTH - FRAGILE-X-SYNDROME
Authors: TSUCHIYA KD FORSYTHE M ROBIN NH TUNNESSEN WW
Citation: Kd. Tsuchiya et al., PICTURE OF THE MONTH - FRAGILE-X-SYNDROME, Archives of pediatrics & adolescent medicine, 152(1), 1998, pp. 89-90
COMPARATIVE EFFICACY OF DIFFERENT PLATELET GPIIB IIIA RECEPTOR ANTAGONISTS ON PLATELET-MEDIATED CLOT STRENGTH USING TISSUE FACTOR-THROMBOELASTOGRAPHY/
Authors: FORSYTHE M MOUSA SA KHURANA S
Citation: M. Forsythe et al., COMPARATIVE EFFICACY OF DIFFERENT PLATELET GPIIB IIIA RECEPTOR ANTAGONISTS ON PLATELET-MEDIATED CLOT STRENGTH USING TISSUE FACTOR-THROMBOELASTOGRAPHY/, The FASEB journal, 12(5), 1998, pp. 4177-4177
XV454, A NOVEL NONPEPTIDE SMALL-MOLECULE PLATELET GIIB IIIA ANTAGONIST WITH COMPARABLE PLATELET ALPHA(IIB)BETA(3)-BINDING KINETICS TO C7E3/
Authors: MOUSA SA FORSYTHE M BOZARTH J YOUSSEF A WITYAK J OLSON R SIELECKI T
Citation: Sa. Mousa et al., XV454, A NOVEL NONPEPTIDE SMALL-MOLECULE PLATELET GIIB IIIA ANTAGONIST WITH COMPARABLE PLATELET ALPHA(IIB)BETA(3)-BINDING KINETICS TO C7E3/, Journal of cardiovascular pharmacology, 32(5), 1998, pp. 736-744
INTRAVENOUS AND ORAL ANTIPLATELET ANTITHROMBOTIC EFFICACY AND SPECIFICITY OF XR300, A NOVEL NONPEPTIDE PLATELET GPIIB/IIIA ANTAGONIST/
Authors: MOUSA SA FORSYTHE M WITYAK J BOZARTH J MU DX
Citation: Sa. Mousa et al., INTRAVENOUS AND ORAL ANTIPLATELET ANTITHROMBOTIC EFFICACY AND SPECIFICITY OF XR300, A NOVEL NONPEPTIDE PLATELET GPIIB/IIIA ANTAGONIST/, Journal of cardiovascular pharmacology, 31(3), 1998, pp. 441-448
DISCOVERY OF NOVEL ORALLY-ACTIVE NONPEPTIDE ANTIPLATELET GPIIB IIIA ANTAGONIST, DMP754 - COMPARATIVE PLATELET BINDING-AFFINITY PROFILES WITH DMP728 AND C7E3/
Authors: MOUSA SA BOZARTH J FORSYTHE M XUE CB WITYAK J OLSON R THOOLEN M REILLY T
Citation: Sa. Mousa et al., DISCOVERY OF NOVEL ORALLY-ACTIVE NONPEPTIDE ANTIPLATELET GPIIB IIIA ANTAGONIST, DMP754 - COMPARATIVE PLATELET BINDING-AFFINITY PROFILES WITH DMP728 AND C7E3/, Thrombosis and haemostasis, 1997, pp. 2707-2707
COMPARISON OF PHENOTYPE BETWEEN PATIENTS WITH PRADER-WILLI-SYNDROME DUE TO DELETION 15Q AND UNIPARENTAL DISOMY-15
Authors: CASSIDY SB FORSYTHE M HEEGER S NICHOLLS RD SCHORK N BENN P SCHWARTZ S
Citation: Sb. Cassidy et al., COMPARISON OF PHENOTYPE BETWEEN PATIENTS WITH PRADER-WILLI-SYNDROME DUE TO DELETION 15Q AND UNIPARENTAL DISOMY-15, American journal of medical genetics, 68(4), 1997, pp. 433-440
ADVANCED LIFE-SUPPORT IN THE WILDERNESS - 5-YEAR EXPERIENCE OF THE REACH AND TREAT TEAM
Authors: SCHMIDT TA FEDERIUK CS ZECHNICH A FORSYTHE M CHRISTIE M ANDREWS C
Citation: Ta. Schmidt et al., ADVANCED LIFE-SUPPORT IN THE WILDERNESS - 5-YEAR EXPERIENCE OF THE REACH AND TREAT TEAM, Wilderness & environmental medicine, 7(3), 1996, pp. 208-215
NOVEL NONPEPTIDE ANTIPLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST, DMP754 - RECEPTOR-BINDING AFFINITY AND SPECIFICITY/
Authors: MOUSA SA FORSYTHE M LORELLI W BOZARTH J XUE CB WITYAK J SIELECKI TM OLSON RE DEGRADO W KAPIL R HUSSAIN M WEXLER R THOOLEN MJ REILLY TM
Citation: Sa. Mousa et al., NOVEL NONPEPTIDE ANTIPLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST, DMP754 - RECEPTOR-BINDING AFFINITY AND SPECIFICITY/, Coronary artery disease, 7(10), 1996, pp. 767-774
PLATELET - ENDOTHELIAL-CELL INTERACTIONS IN MEDIATING THE RELEASE OF PLASMINOGEN-ACTIVATOR INHIBITOR-1
Authors: MOUSA SA FORSYTHE M REILLY TM
Citation: Sa. Mousa et al., PLATELET - ENDOTHELIAL-CELL INTERACTIONS IN MEDIATING THE RELEASE OF PLASMINOGEN-ACTIVATOR INHIBITOR-1, Biochemical archives, 12(2), 1996, pp. 43-53
FEW PHENOTYPIC DIFFERENCES BETWEEN PATIENTS WITH PRADER-WILLI-SYNDROME DUE TO DELETION 15Q AND UNIPARENTAL DISOMY-15
Authors: CASSIDY SB FORSYTHE M HEEGER S NICHOLLS R SWARTZ S
Citation: Sb. Cassidy et al., FEW PHENOTYPIC DIFFERENCES BETWEEN PATIENTS WITH PRADER-WILLI-SYNDROME DUE TO DELETION 15Q AND UNIPARENTAL DISOMY-15, American journal of medical genetics, 64(4), 1996, pp. 6-6
INTRAVENOUS AND ORAL ANTIPLATELET ANTITHROMBOTIC EFFICACY AND SPECIFICITY OF XR300, A NOVEL NON PEPTIDE PLATELET GPIIB/IIIA ANTAGONIST/
Authors: MOUSA SA BOZARTH J FORSYTHE M WITYAK J REILLY TM MU DX
Citation: Sa. Mousa et al., INTRAVENOUS AND ORAL ANTIPLATELET ANTITHROMBOTIC EFFICACY AND SPECIFICITY OF XR300, A NOVEL NON PEPTIDE PLATELET GPIIB/IIIA ANTAGONIST/, Circulation, 94(8), 1996, pp. 569-569
DISCOVERY OF A NOVEL NON PEPTIDE ANTIPLATELET GPIIB IIIA RECEPTOR ANTAGONIST, DMP-754 - RECEPTOR-BINDING AFFINITY AND SPECIFICITY/
Authors: MOUSA SA BOZARTH J FORSYTHE M XUE CB WITYAK J OLSON R THOOLEN MJ REILLY TM
Citation: Sa. Mousa et al., DISCOVERY OF A NOVEL NON PEPTIDE ANTIPLATELET GPIIB IIIA RECEPTOR ANTAGONIST, DMP-754 - RECEPTOR-BINDING AFFINITY AND SPECIFICITY/, Circulation, 94(8), 1996, pp. 3006-3006
ANTITHROMBOTIC AND THROMBOLYTIC EFFICACY OF THE PLATELET GPIIB IIIA ANTAGONIST DMP-728 IN ARTERIAL THROMBOSIS RETHROMBOSIS MODELS/
Authors: MOUSA SA MU DX FORSYTHE M LUCCHESI BR REILLY TM
Citation: Sa. Mousa et al., ANTITHROMBOTIC AND THROMBOLYTIC EFFICACY OF THE PLATELET GPIIB IIIA ANTAGONIST DMP-728 IN ARTERIAL THROMBOSIS RETHROMBOSIS MODELS/, Thrombosis and haemostasis, 73(6), 1995, pp. 1313-1313
PHENOTYPIC DIFFERENCES BETWEEN PATIENTS WITH PRADER-WILLI-SYNDROME DUE TO DELETION 15Q AND UNIPARENTAL DISOMY-15
Authors: CASSIDY SB FORSYTHE M HEEGER S NICHOLLS RD SCHWARTZ S
Citation: Sb. Cassidy et al., PHENOTYPIC DIFFERENCES BETWEEN PATIENTS WITH PRADER-WILLI-SYNDROME DUE TO DELETION 15Q AND UNIPARENTAL DISOMY-15, American journal of human genetics, 57(4), 1995, pp. 88-88
PURCHASING VASCULAR SERVICES - DEVELOP SPECIALIZED UNITS
Authors: FORSYTHE M
Citation: M. Forsythe, PURCHASING VASCULAR SERVICES - DEVELOP SPECIALIZED UNITS, BMJ. British medical journal, 309(6958), 1994, pp. 881-881
NEW NHS COMPLAINTS PROCEDURE
Authors: FORSYTHE M
Citation: M. Forsythe, NEW NHS COMPLAINTS PROCEDURE, BMJ. British medical journal, 308(6940), 1994, pp. 1315-1316
LADY PEARCE,PATRICIA - OBITUARY
Authors: FORSYTHE M
Citation: M. Forsythe, LADY PEARCE,PATRICIA - OBITUARY, BMJ. British medical journal, 308(6935), 1994, pp. 1037-1037
ARBITRATION AND THE INTERNAL MARKET
Authors: FORSYTHE M
Citation: M. Forsythe, ARBITRATION AND THE INTERNAL MARKET, BMJ. British medical journal, 308(6922), 1994, pp. 151-152
ROLE OF PLATELET GPIIB IIIA RECEPTORS IN THE MODULATION OF PLATELET PLASMINOGEN-ACTIVATOR INHIBITORS TYPE-1 (PAI-1) RELEASE/
Authors: MOUSA SA BOZARTH J FORSYTHE M TSAO P PEASE L REILLY TM
Citation: Sa. Mousa et al., ROLE OF PLATELET GPIIB IIIA RECEPTORS IN THE MODULATION OF PLATELET PLASMINOGEN-ACTIVATOR INHIBITORS TYPE-1 (PAI-1) RELEASE/, Life sciences, 54(16), 1994, pp. 1155-1162
NEW MODEL NEEDED FOR CONSULTANT CONTRACT
Authors: FORSYTHE M
Citation: M. Forsythe, NEW MODEL NEEDED FOR CONSULTANT CONTRACT, BMJ. British medical journal, 306(6889), 1993, pp. 1417-1417
TERTIARY EXTRACONTRACTUAL REFERRALS
Authors: FORSYTHE M
Citation: M. Forsythe, TERTIARY EXTRACONTRACTUAL REFERRALS, BMJ. British medical journal, 306(6886), 1993, pp. 1199-1199
Risultati: 1-21 |